37 employees
A multinational clinical stage biotechnology company.
2007
$76M
from 6 investors over 6 rounds
KBP Biosciences raised $76M on January 5, 2018
Investors: Korea Investment Partners, Sangel Capital, Cowin Venture Capital, Bay City Capital, Efung Capital and PingAn Ventures